SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
17576943
Source:
http://linkedlifedata.com/resource/pubmed/id/17576943
Search
Subject
(
52
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0008976
,
umls-concept:C0011633
,
umls-concept:C0030705
,
umls-concept:C0087111
,
umls-concept:C0393022
,
umls-concept:C0473169
pubmed:issue
6
pubmed:dateCreated
2007-6-19
pubmed:abstractText
Dermatomyositis is an autoimmune disease that is associated with muscle and skin inflammation. Using quantitative scales, we sought to evaluate the effects of rituximab therapy on muscle strength and skin disease in patients with dermatomyositis.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0372433
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal
,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal...
,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Creatine Kinase
,
http://linkedlifedata.com/resource/pubmed/chemical/rituximab
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0003-987X
pubmed:author
pubmed-author:ChungLorindaL
,
pubmed-author:FiorentinoDavid FDF
,
pubmed-author:GenoveseMark CMC
pubmed:issnType
Print
pubmed:volume
143
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
763-7
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:17576943-Adult
,
pubmed-meshheading:17576943-Aged
,
pubmed-meshheading:17576943-Antibodies, Monoclonal
,
pubmed-meshheading:17576943-Antibodies, Monoclonal, Murine-Derived
,
pubmed-meshheading:17576943-Antineoplastic Agents
,
pubmed-meshheading:17576943-Cohort Studies
,
pubmed-meshheading:17576943-Creatine Kinase
,
pubmed-meshheading:17576943-Dermatomyositis
,
pubmed-meshheading:17576943-Female
,
pubmed-meshheading:17576943-Humans
,
pubmed-meshheading:17576943-Male
,
pubmed-meshheading:17576943-Middle Aged
,
pubmed-meshheading:17576943-Muscle Strength
,
pubmed-meshheading:17576943-Pilot Projects
,
pubmed-meshheading:17576943-Severity of Illness Index
,
pubmed-meshheading:17576943-Treatment Outcome
pubmed:year
2007
pubmed:articleTitle
A pilot trial of rituximab in the treatment of patients with dermatomyositis.
pubmed:affiliation
Department of Medicine, Stanford University School of Medicine, 900 Blake Wilbur Dr, Stanford, CA 94305, USA.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Research Support, Non-U.S. Gov't